Chronic Disease Management
More stories
-
Active Plant Substance Reduces Pulmonary Hypertension
What Causes Pulmonary Hypertension and How Can it be Treated? Introduction Pulmonary hypertension is a rare but serious disease that affects the blood vessels in the lungs. Blood pressure in the lungs is usually lower than in the rest of the body, but pulmonary hypertension occurs when the blood vessels in the lungs contract, causing […] More
-
Why Fabry Disease Treatment Can’t be a One-Size-Fits-All Solution for My Family
Straight Paths with Crooked Lines: Navigating Enzyme Replacement Therapies for Fabry Disease Fabry disease is a genetic disorder that causes a lack of an enzyme called alpha-galactosidase A (Gal A) which results in the accumulation of a type of fat called globotriaosylceramide (Gb3 or GL-3) inside cells, causing multisystemic damage. This disease affects males and […] More
-
Revolutionary Research on Angiogenic Therapies for Ischemic Disease: Frontiers’ Latest Topic
Enhancing the Efficacy of Angiogenic Therapies for Ischemic Diseases Introduction Ischemic cardiovascular diseases remain the leading cause of death worldwide, affecting hundreds of millions of patients. The prevalence of the disease is estimated to increase with the ageing of the population. Clinical management of ischemic diseases mainly focuses on prevention and treatment of atherosclerotic arterial […] More
-
Sotorasib: The Promising Treatment for KRAS-Related Vascular Malformations
Treating KRAS G12C-Related Arteriovenous Malformations with Sotorasib A small French study revealed that treating severe KRAS G12C-related arteriovenous malformations with sotorasib (Lumakras) was effective. The study showed that the KRAS inhibitor can significantly reduce symptoms and malformation size. This article will discuss the study in detail and its implications for treating vascular malformations. What are […] More
-
SEL-212 Therapy Elevates Quality of Life for Gout Patients HCPLive
Study Shows SEL-212 Treatment Improves Quality of Life for Gout Patients About the Study A recent study presented at the 2024 European Congress of Rheumatology (EULAR) has shown that patients with gout refractory to standard treatment who received SEL-212 in either low dose (LD; 0.1 mg/kg) or high dose (HD; 0.15 mg/kg) formulations experienced improvements […] More
-
Hot
Dr Grunwald Reveals Fascinating Insight into Rates of Disease Progression in Low-Risk Myelofibrosis
Understanding Disease Progression in Low-Risk Myelofibrosis Patients Introduction Myelofibrosis is a rare type of cancer of the bone marrow that causes abnormal scar tissue to form. This scarring can cause a number of unpleasant symptoms, such as fatigue, anemia, and abdominal discomfort. However, not all patients with myelofibrosis experience the same level of disease progression. […] More
-
Kate Middleton Makes Progress in Cancer Treatment
Kate Middleton Provides Update on Chemotherapy Treatment Progress Kate Middleton, the Princess of Wales, provided an update on her chemotherapy treatment progress through a post on the Kensington Royal Twitter account on Friday. The princess expressed gratitude for the overwhelming support, which has helped her and William, her husband, navigate through some difficult times. Attending […] More
-
Halsey Lucky to be Alive Amid Health Battle NBC 5 Dallas-Fort Worth
Halsey Opens Up About Health Struggles in “The End” Release The Details On June 4, Halsey revealed on Instagram that she has been dealing with a serious health issue for the past few years, although she didn’t offer specifics on her diagnosis. She did disclose, however, that her disorder is serious enough that she considers […] More